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Figure	  1.	  Example	  of	  skin	  cancer	  risk	  factors	  on	  the	  back	  of	  a	  55	  years	  old	  man,	  including	  high	  nevus	  count	  (>50),	  
presence	  of	  atypical	  nevi	  and	  lenNgines,	  as	  well	  as	  suspected	  melanomas.	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IntroducNon.	   Sunbed	   use	   has	   been	   signiﬁcantly	   associated	   with	   increased	   risk	   of	  
melanoma	   and	   non-­‐melanoma	   skin	   cancer	   (NMSC),	   but	   its	   rela<onship	   with	  
melanoma’s	  risk	  factors	  such	  as	  high	  nevus	  count,	  atypical	  nevi	  and	  len<gines	  (Figure	  1)	  
is	   poorly	   studied.	   Euromelanoma	   is	   a	   skin	   cancer	   preven<on	   campaign	   conducted	   all	  
over	  Europe.	  It	  oﬀers	  a	  once-­‐a-­‐year	  screening	  during	  which	  par<cipants’	  data,	  including	  
sunbed	  use	  and	  phenotype,	  are	  collected	  via	  ques<onnaires.	  
	  
ObjecNves.	   To	   inves<gate	   the	   associa<on	   of	   sunbed	   use	   with	   nevus	   count,	   atypical	  
nevi,	  len<gines	  and	  suspicion	  of	  skin	  cancer.	  
	  
Material	   and	   methods.	   To	   ensure	   reliability	   of	   the	   data,	   we	   deﬁned	   inclusion	   and	  
exclusion	   criteria	   for	   countries’	   eligibility	   for	   the	   risk	   analysis.	   Mul<variate	   logis<c	  
regression	   models	   (including	   age,	   gender,	   educa<on,	   skin	   type,	   family	   history	   of	  
melanoma,	  personal	  history	  of	  skin	  cancer,	  any	  sun	  exposure,	  and	  any	  sunscreen	  use)	  
were	  used	   to	  calculate	  summary	  odds	   ra<os	   (SORs)	  of	  each	  clinical	  endpoint	   for	  ever	  
sunbed	  use.	  
	  
Results.	  Overall,	  227,888	   individuals	   from	  30	  countries	  completed	  the	  Euromelanoma	  
ques<onnaire.	   Aier	   the	   data	   quality	   check,	   16	   countries	   were	   eligible	   for	   the	  
mul<variate	  analysis,	  for	  a	  total	  of	  145,980	  par<cipants	  (64.8%	  females;	  median	  age	  43	  
years;	  62.3%	  highly	  educated;	  28.5%	  skin	  type	  I-­‐II;	  11.0%	  ever	  sunbed	  use).	  Ever	  sunbed	  
use	  was	  independently	  associated	  with	  suspicion	  of	  melanoma	  [SOR=1.13	  (1.00-­‐1.27)]	  
(Figure	   2A),	   nevus	   count	   >50	   [SOR=1.05	   (1.01-­‐1.10)]	   (Figure	   2B),	   atypical	   nevi	  
[SOR=1.04	   (1.00-­‐1.09)]	   (Figure	   2C),	   and	   len<gines	   [SOR=1.16	   (1.04-­‐1.29)]	   (Figure	   2D).	  
Conversely	   no	   signiﬁcant	   associa<on	   was	   found	   between	   ever	   sunbed	   use	   and	  
suspicion	  of	  NMSC	  [SOR=1.00	  (0.91-­‐1.10)].	  
Conclusions.	  Indoor	  tanning	  is	  signiﬁcantly	  associated	  with	  well-­‐recognised	  risk	  factors	  for	  melanoma	  (including	  high	  nevus	  count,	  presence	  of	  atypical	  nevi	  and	  len<gines)	  as	  well	  as	  
suspicion	  of	  melanoma	  within	  the	  Euromelanoma	  screenees.	  In	  order	  to	  reduce	  the	  prevalence	  of	  melanoma	  risk	  factors,	  avoidance/discon<nua<on	  of	  sunbed	  use	  should	  always	  be	  
encouraged,	  especially	  but	  not	  exclusively	  for	  individuals	  with	  high-­‐risk	  phenotypes.	  
Figure	   2.	   Forest	   plots	   of	   associaNon	   of	  
suspected	   melanoma	   (A),	   high	   nevus	   count	  
(>50	   nevi)	   (B),	   ≥1	   atypical	   nevus	   (C),	  
lenNgines	  on	  back/chest	  (D)	  with	  ever	  use	  of	  
sunbeds.	  	  
All	   odds	   ra<os	   are	   adjusted	   for	   age,	   gender,	  
educa<on,	   skin	   type,	   family	   history	   of	  
melanoma,	   personal	   history	   of	   skin	   cancer,	  
any	   sun	   exposure,	   and	   any	   sunscreen	   use.	  
FYROM,	   Former	   Yugoslav	   Republic	   of	  
Macedonia.	  	  
Heterogeneity	   I2=11%	   (suspected	  melanoma),	  
I2=0%	   (high	   nevus	   count),	   I2=0%	   (≥1	   atypical	  
nevus),	  I2=68%	  (len<gines)	  for	  all	  countries.	  	  
	  
1In	   order	   to	   calculate	   the	   odds	   ra<o	   for	  
Georgia,	   the	   model	   for	   this	   country	   was	   not	  
adjusted	   for	   age,	   skin	   type	   and	   personal	  
history	   of	   skin	   cancer,	   due	   to	   frequency	   of	  
suspected	   melanoma	   being	   too	   low	   in	  
exposed	  individuals.	  	  
	  
2A	   sensi<vity	   analysis	   for	   Ireland,	   the	   only	  
country	   with	   a	   considerable	   amount	   of	  
missing	   data	   on	   sunbed	   use	   (20.3%,	  
Supplementary	  Table	  S2)	   found	  that	  the	  odds	  
ra<o	  of	   suspected	  melanoma	  associated	  with	  
the	   missing	   values	   was	   similar	   to	   the	   odds	  
ra<o	  for	  exposed	  individuals	  [6.31	  (0.74-­‐53.71)	  
and	  6.27	  (0.69-­‐57.27),	  respec<vely].	  	  
	  
3The	  odds	   ra<o	   for	   Ireland	  was	  not	   available,	  
due	   to	   frequency	   of	   high	   nevus	   count	   being	  
too	  low	  in	  exposed	  individuals.	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